To ensure consistency in contemporary classifications of BC based on molecular subtypes, the scope of this review was limited to luminal A, luminal B, HER2-overexpressing, and TNBC/basal-like breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.